PORTFOLIO
Solve Ventures’ investment team have identified and invested in some of the most groundbreaking digital health deals.
Citus Health
Citus Health develops technology-driven solutions for home infusion providers and their patients which dramatically improves the patient experience and reduces administrative overhead.
Latest News
JANUARY 16, 2019 FountainRx Partners with Citus Health to Optimize Patient Engagement and Onboarding
DECEMBER 04, 2018 Santa Barbara Specialty Pharmacy Selects MHALink™ Powered By Citus Health to Streamline Patient Engagement and Automate Processes with Digital Workflows
ICBI
ICBI has developed a molecule for early detection and treatment of Parkinson’s disease. ICBI’s patented SMART Molecule penetrates the blood-brain barrier (BBB) using tech-enabled science to transform the diagnosis, monitoring, and treatment of this debilitating neurodegenerative disease that impacts millions of lives and costs the healthcare system billions of dollars annually.
Latest News
DECEMBER 6, 2017 ICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
Moving Analytics
Moving Analytics provides intuitive, turnkey, home-based post-acute care management solutions for cardiopulmonary disease that improves patient outcomes, reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Latest News
OCTOBER 21, 2018 Pitch Perfect Winner Spotlight: The startup tackling cardiac rehab with technology
OCTOBER 5, 2018 Vizient, Inc. Announces Moving Analytics as the 2018 Innovation Challenge Winner
PhysicianAssist
PhysicianAssist delivers highly-skilled, ”on-call” virtual medical scribes to perform electronic health record charting, queuing of diagnostic orders and on-demand tasks. The service is designed to restore the patient experience and relieve physicians of tedious data entry.
Latest News
No new stories.